> Details

Borroni, Edilio; Bohrmann, Bernd; Grueninger, Fiona; Prinssen, Eric; Nave, Stephane; Loetscher, Hansruedi; Chinta, Shankar J; Rajagopalan, Subramanian; Rane, Anand; Siddiqui, Almas; Ellenbroek, Bart; Messer, Juerg; Pähler, Axel; Andersen, Julie K; Wyler, Rene; Cesura, Andrea M

Sembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer’s Disease

Reference
management

Bookmarks

Remove from
bookmarks

Share this on Whatsapp

Close

Bookmarks



You can manage bookmarks using lists, please log in to your user account for this.
  • Media type: E-Article
  • Title: Sembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer’s Disease
  • Contributor: Borroni, Edilio; Bohrmann, Bernd; Grueninger, Fiona; Prinssen, Eric; Nave, Stephane; Loetscher, Hansruedi; Chinta, Shankar J; Rajagopalan, Subramanian; Rane, Anand; Siddiqui, Almas; Ellenbroek, Bart; Messer, Juerg; Pähler, Axel; Andersen, Julie K; Wyler, Rene; Cesura, Andrea M
  • imprint: American Society for Pharmacology & Experimental Therapeutics (ASPET), 2017
  • Published in: Journal of Pharmacology and Experimental Therapeutics
  • Language: English
  • DOI: 10.1124/jpet.117.241653
  • ISSN: 0022-3565; 1521-0103
  • Keywords: Pharmacology ; Molecular Medicine
  • Origination:
  • Footnote:
  • Access State: Open Access